-
1
-
-
46849083120
-
Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
-
Kitahara K, Tagaki K, Kusonoki Y, et al. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Ann Rheum Dis 2008;67:1059-60.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1059-1060
-
-
Kitahara, K.1
Tagaki, K.2
Kusonoki, Y.3
-
2
-
-
33846066344
-
Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis
-
Matsui T, Shimada K, Ozawa N, et al. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. J Rheumatol 2006;33:2390-7.
-
(2006)
J Rheumatol
, vol.33
, pp. 2390-2397
-
-
Matsui, T.1
Shimada, K.2
Ozawa, N.3
-
3
-
-
18744430797
-
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
-
Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2741-2749
-
-
Rantapaa-Dahlqvist, S.1
de Jong, B.A.2
Berglin, E.3
-
4
-
-
8444238975
-
The presence of citrullinated proteins is not specific for rheumatoid synovial tissue
-
Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 2004;50:3485-94.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 3485-3494
-
-
Vossenaar, E.R.1
Smeets, T.J.2
Kraan, M.C.3
Raats, J.M.4
van Venrooij, W.J.5
Tak, P.P.6
-
5
-
-
0029123518
-
Clinical case seminar: Lymphocytic hypophysitis: clinicopathological findings
-
Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S. Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 1995;80:2302-11.
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 2302-2311
-
-
Thodou, E.1
Asa, S.L.2
Kontogeorgos, G.3
Kovacs, K.4
Horvath, E.5
Ezzat, S.6
-
6
-
-
27144453668
-
Endogenous hypercortisolism and immunologically-mediated disease: Three cases
-
Sahli R, Diem P, Christ ER. Endogenous hypercortisolism and immunologically-mediated disease: three cases. Dtsch Med Wochenschr 2005;130:2316-8.
-
(2005)
Dtsch Med Wochenschr
, vol.130
, pp. 2316-2318
-
-
Sahli, R.1
Diem, P.2
Christ, E.R.3
-
7
-
-
35148856222
-
Hypothyroidism presenting as puzzling myalgias and cramps in 3 patients
-
Georg G. Hypothyroidism presenting as puzzling myalgias and cramps in 3 patients. J Clin Rheumatol 2007;13:273-5.
-
(2007)
J Clin Rheumatol
, vol.13
, pp. 273-275
-
-
Georg, G.1
-
8
-
-
23744474922
-
Autoimmune hypophysitis
-
Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR. Autoimmune hypophysitis. Endocr Rev 2005;26:599-614.
-
(2005)
Endocr Rev
, vol.26
, pp. 599-614
-
-
Caturegli, P.1
Newschaffer, C.2
Olivi, A.3
Pomper, M.G.4
Burger, P.C.5
Rose, N.R.6
-
9
-
-
34547256500
-
Folliculo-stellate cells of "true dendritic" type are involved in the inflammatory microenvironment of tumor immunosurveillance of pituitary adenomas
-
Vajtai I, Kappeler A, Sahli R. Folliculo-stellate cells of "true dendritic" type are involved in the inflammatory microenvironment of tumor immunosurveillance of pituitary adenomas. Diagn Pathol 2007;2:20.
-
(2007)
Diagn Pathol
, vol.2
, pp. 20
-
-
Vajtai, I.1
Kappeler, A.2
Sahli, R.3
-
10
-
-
34347266588
-
Autoimmune hypophysitis: An underestimated disease in search of its autoantigen(s)
-
Caturegli P. Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). J Clin Endocrinol Metab 2007;92:2038-40.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 2038-2040
-
-
Caturegli, P.1
-
11
-
-
23644455857
-
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial
-
Kremer JM, Dougados M, Emery P, et al. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005;52:2263-71.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 2263-2271
-
-
Kremer, J.M.1
Dougados, M.2
Emery, P.3
|